Updated:
Finnova Capital
Finnova Capital is a China-based venture capital firm investing in energy-saving, clean energy, healthcare, information technology, new materials, and...
Finnova Capital
Finnova Capital is a China-based venture capital firm investing in energy-saving, clean energy, healthcare, information technology, new materials, and other areas. The firm has made 28 investments, including a Seed VC investment in Crygan on March 12, 2026. Finnova Capital has facilitated 3 portfolio exits, with Bao Pharma exiting on December 10, 2025.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What stages does Finnova Capital invest across?
Finnova deploys capital across the full lifecycle of private Chinese companies, from early-stage seed and start-up venture rounds through growth equity and expansion capital. The firm also executes pre-IPO placements and participates in PIPE transactions, which allows it to back companies from initial institutional funding through to public-market adjacency. This multi-stage approach is designed to capture value across the entire private growth curve.
Is Finnova Capital a domestic Chinese fund or does it have an offshore structure?
Finnova Capital operates as a Beijing-headquartered asset manager focused almost exclusively on domestically incorporated Chinese portfolio companies. There is no public record of significant offshore fund vehicles or a Cayman Islands master-feeder structure, which is typical for Chinese GPs raising foreign LP capital. Its mandate and deal flow appear entirely Renminbi-denominated and mainland-facing.
How does Finnova source its deals?
Based on its Beijing location and investment-stage breadth, Finnova likely sources through a combination of direct founder relationships, state-owned enterprise spinouts, university technology-transfer programs, and referrals from securities brokerages involved in its PIPE transactions. The firm maintains an intentionally low public profile, suggesting its origination relies on closed-network referrals rather than auction processes or intermediary-led mandates.
Does Finnova Capital participate in fund commitments from foreign limited partners?
There is no available evidence that Finnova has historically raised capital from foreign LPs. Its operational footprint, Renminbi deal activity, and lack of a disclosed offshore structure indicate it is funded by domestic Chinese institutional investors, high-net-worth individuals, or proprietary capital from its founding principals.
What sectors does Finnova Capital target?
Specific sector mandates are not formally disclosed by the firm. However, a Beijing-based PE manager with a venture-to-PIPE throughput in the current Chinese market is typically concentrated in advanced manufacturing, semiconductors, enterprise software, new materials, and healthcare technology — sectors prioritized under China's industrial policy and equity market reforms. Finnova's multi-stage approach suggests it is agnostic enough to rotate capital into whatever verticals are currently producing IPO pipeline candidates on the STAR Market or ChiNext board.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: